Related Experiment Videos
Assessment of high-frequency neonatal ventilator performances
1Service de Réanimation Pédiatrique Polyvalente, Hôpital Necker Enfants Malades, Paris.
Intensive Care Medicine
|February 1, 1997
Summary
Two neonatal ventilators provided adequate tidal volumes, but two models showed decreased delivery with increased lung compliance or decreased mean airway pressure. This may explain unexplained hypercapnia in infants.
Area of Science:
- Neonatal critical care medicine
- Respiratory physiology
- Biomedical engineering
Background:
- Neonatal high-frequency ventilation (HVF) is crucial for treating respiratory distress in premature infants.
- Assessing the performance and reliability of different HVF devices is essential for optimizing patient care.
Purpose of the Study:
- To evaluate the efficacy and reliability of three neonatal high-frequency ventilators.
- To compare tidal volume delivery across different settings and patient conditions.
Main Methods:
- Bench evaluation of three neonatal high-frequency ventilators (HFV-Babylog 8000, OHF 1, SensorMedics 3100A) using a neonatal test-lung.
- Measurements included tidal volume, peak-to-peak pressure, and mean airway pressure under varying ventilator settings, endotracheal tube sizes, and lung compliances.
Main Results:
- Two ventilators (OHF 1, SensorMedics 3100A) delivered adequate tidal volumes at 15 Hz, irrespective of endotracheal tube size or lung mechanics.
- The HFV-Babylog 8000 showed reduced tidal volume delivery above 50% pressure amplitude and with decreasing mean airway pressure.
- Tidal volume increased with endotracheal tube size for all ventilators; only OHF 1 showed decreased tidal volume with increased lung compliance.
Conclusions:
- Two of the three tested neonatal ventilators demonstrated reliable tidal volume delivery under standard conditions.
- Ventilator-specific responses to changes in lung compliance and mean airway pressure may contribute to unexplained hypercapnia in neonates during recovery from conditions like hyaline membrane disease.